Intranodal Treatment With Ifnα-Dendritic Cells and Rituximab Induces Systemic Clinical Response and Endogenous Vaccination Against Follicular Lymphoma: Final Result of a Phase I Study
Hematological Oncology - United Kingdom
doi 10.1002/hon.126_2630
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley